Observational studyFrontiers in immunology2025

Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland.

Renata Pacholczak-Madej et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.